TickerFactsScreenerDevelopers

GALECTIN THERAPEUTICS INC (GALT) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2009: $251.0K2010: $5.89M2011: $6.40M2012: $9.36M2013: $10.49M2014: $29.13M2015: $25.85M2016: $15.36M2017: $3.05M2018: $8.25M2019: $47.48M2020: $27.14M2021: $39.65M2022: $18.59M2023: $25.66M2024: $15.12M2025: $17.72M$17.72M
2009Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$17.72M+17.2%
2024$15.12M-41.1%
2023$25.66M+38.0%
2022$18.59M-53.1%
2021$39.65M+46.1%
2020$27.14M-42.8%
2019$47.48M+475.3%
2018$8.25M+170.3%
2017$3.05M-80.1%
2016$15.36M-40.6%
2015$25.85M-11.3%
2014$29.13M+177.7%
2013$10.49M+12.0%
2012$9.36M+46.4%
2011$6.40M+8.6%
2010$5.89M+2247.0%
2009$251.0K—